MedPath

NB-PREGABALIN

NB-PREGABALIN

Approved
DIN Number

02554844

Drug Class

Human

Market Date

Jun 5, 2025

Company
HC

nb pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02554844
AIG Number0151121002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF02 PREGABALIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

PREGABALINActive
Strength: 50 MG
Monograph: PREGABALIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.